Page last updated: 2024-11-03

pramoxine and Essential Tremor

pramoxine has been researched along with Essential Tremor in 1 studies

pramoxine: RN given refers to parent cpd; structure
pramocaine : A member of the class of morpholines that is morpholine substituted at the nitrogen atom by a 3-(4-butoxyphenoxy)propyl group.

Essential Tremor: A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)

Research Excerpts

ExcerptRelevanceReference
"Essential tremor is the most common movement disorder with clear unmet need."1.72Translational Pharmacology of PRAX-944, a Novel T-Type Calcium Channel Blocker in Development for the Treatment of Essential Tremor. ( Belfort, GM; Hughes, ZA; Matthews, LG; Puryear, CB; Raines, S; Ravina, B; Scott, L; Wittmann, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Scott, L1
Puryear, CB1
Belfort, GM1
Raines, S1
Hughes, ZA1
Matthews, LG1
Ravina, B1
Wittmann, M1

Other Studies

1 other study available for pramoxine and Essential Tremor

ArticleYear
Translational Pharmacology of PRAX-944, a Novel T-Type Calcium Channel Blocker in Development for the Treatment of Essential Tremor.
    Movement disorders : official journal of the Movement Disorder Society, 2022, Volume: 37, Issue:6

    Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Drug Development; Essential Tremor; Rat

2022